ONCY News

Latest breaking news and updates for ONCY stock.

Track all markets on TradingView

Cancer Treatment Stocks Surge as $866B Market Attracts Private Investment

USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Aug. 14, 2025 /PRNewswire/ -- USA News Group News Commentary – Federal budget cuts have put pressure on can...

What macroeconomic or market risks could offset the positive impact of the private investment on the stock? How does ONCY’s cash runway and burn rate compare after factoring in the new private investment? What regulatory milestones are upcoming for ONCY’s product candidates that could be influenced by this private funding?
Investments
11 days ago
Read more prnewswire

Oncolytics Biotech® Announces Voting Results from the Annual General Meeting of Shareholders

SAN DIEGO, Aug. 11, 2025 /PRNewswire/ -- Oncolytics Biotech® Inc. (Nasdaq: ONCY) (TSX: ONC) ("Oncolytics" or the "Corporation" or the "Company"), a clinical-stage immunotherapy company developing p...

What are the potential short‑term and long‑term effects on ONCY's stock price? How might the AGM outcomes impact the company's pipeline and funding for pelareorep development? Are there any upcoming regulatory or compliance implications stemming from the AGM decisions?
Governance
14 days ago
Read more prnewswire

Oncolytics Biotech® Announces Voluntary Delisting from the Toronto Stock Exchange

SAN DIEGO, Aug. 8, 2025 /PRNewswire/ -- Oncolytics Biotech® Inc. (Nasdaq: ONCY) (TSX: ONC) ("Oncolytics" or the "Company"), a clinical-stage immunotherapy company developing pelareorep, today annou...

What are the potential long‑term implications for the stock’s valuation and inclusion in index funds? Could the delisting trigger a re‑rating or coverage change by analysts covering ONCY? Is there any anticipated change in the company’s dividend policy or share buy‑back program due to the delisting?
Listing
18 days ago
Read more prnewswire